UBS analysts increased the price target on Axsome Therapeutics (NASDAQ:AXSM) shares to $133.00, up from the previous $105.00, while maintaining a Buy rating on the stock. The company, currently valued ...
UBS should have more clarity on the amount of capital it will need to hold under new Swiss banking regulations currently being drawn up, CEO Sergio Ermotti said on Monday.
Diane Hart built her practice as a sole practitioner by connecting with Asian American clients and leveraging her unique cultural perspective.
UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...
Deutsche Bank (ETR:DBKGn) analyst Benjamin Goy upgraded UBS AG (UBSG:SW) (NYSE: UBS) stock rating from Hold to Buy and increased the price target from CHF29.00 to CHF37.00. Goy noted that UBS's share ...
Some big Wall Street firms are facing new complications that were not part of the plan when Donald Trump was elected in November.
Wells Fargo Advisors, the bank’s brokerage unit, recruited a former UBS advisor team that oversaw $1.6 billion in assets ...
UBS should have more clarity on the amount of capital it will need to hold under new Swiss banking regulations currently ...
Deutsche Bank analyst Benjamin Goy upgraded UBS (UBS) to Buy from Hold with a price target of CHF 37, up from CHF 29. The bank decided to ...
A former UBS bond strategist who persuaded the U.S. Supreme Court to make it easier for corporate whistleblowers to win ...
Inflexion has named Ben Meyer as a partner and head of North America. Meyer will lead a new office for Inflexion in New York.
Major financial institutions are raising their gold price forecasts due to growing trade war fears and central bank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results